Diagnostics

Manufacturing Systems Built for Accuracy, Scale, and Supply-Chain Reality

Dharma Biologics | Bengaluru, India

Diagnostics do not fail quietly. When they fail, they do so at scale—across hospitals, laboratories, field sites, and supply chains. The consequences are not abstract: delayed diagnoses, incorrect results, interrupted testing programs, and regulatory intervention. In diagnostics, manufacturing discipline is not a competitive advantage; it is the price of entry.

Dharma Biologics was built to support diagnostics as manufacturing systems, not one-off reagent builds. We design processes that produce the same result on the millionth unit as on the first, under regulatory scrutiny, variable logistics, and real-world use.

As the highest-quality CDMO in India, supported by deep technical and operational backing from the CDMO Network, Dharma Biologics offers diagnostic companies something essential and increasingly rare: reproducibility at scale without compromise.

Diagnostics Are Supply-Chain Products, Not Lab Experiments

Many diagnostic programs originate in research environments optimized for discovery, not repeatability. Early success often masks structural weaknesses: unstable expression systems, purification schemes sensitive to minor variation, or quality controls that do not translate to production volumes.

Dharma Biologics intervenes early to convert diagnostic biology into manufacturable architecture. We align expression systems, fermentation strategies, downstream purification, and QC frameworks so that diagnostic components behave consistently across batches, sites, and time.

This is how diagnostics survive scale.

Core Diagnostic Modalities We Support

Dharma Biologics supports diagnostic developers across molecular diagnostics, immunoassays, enzymatic assays, and emerging biosensor platforms. Our strength lies not in any single reagent type, but in how we integrate multiple components into reliable supply systems.

Recombinant Enzymes for Molecular Diagnostics

Enzymes are the backbone of modern molecular diagnostics. Their performance must remain stable across temperature fluctuations, transport stress, and repeated use.

Dharma Biologics manufactures diagnostic enzymes using microbial expression platforms optimized for activity, purity, and consistency.

We support enzymes including (but not limited to):

  • DNA polymerases (including strand-displacing and thermostable variants)
  • Reverse transcriptases
  • RNase inhibitors
  • Ligases and nucleases
  • Enzymes for isothermal amplification systems

Our enzyme programs emphasize:

  • Activity retention over shelf life
  • Tight impurity and endotoxin control
  • Batch-to-batch reproducibility
  • Scalable fermentation and purification

We design enzyme processes that diagnostics companies can rely on—not babysit.

Antigens & Recombinant Proteins for Immunoassays

Immunoassays are only as reliable as the antigens they use. Variability in folding, glycosylation (where applicable), or impurity profiles can distort assay performance in subtle but dangerous ways.

Dharma Biologics produces recombinant antigens and proteins with structural and functional consistency, supporting applications such as:

  • ELISA
  • CLIA
  • Lateral flow assays
  • Multiplex immunoassays

We support:

  • Bacterial and yeast expression
  • Soluble and refolded protein strategies
  • Controlled purification trains
  • Structural and binding-characterization analytics

Antigen quality is treated as a performance variable, not a background assumption.

Antibody Fragments & Binding Reagents

Many modern diagnostic platforms rely on antibody fragments, nanobodies, or engineered binding proteins rather than full-length antibodies. These molecules introduce unique expression and stability challenges.

Dharma Biologics supports:

  • scFv and Fab fragments
  • Single-domain antibodies
  • Engineered affinity reagents
  • Diagnostic-specific binding constructs

We design expression systems to maximize yield while preserving binding performance, and we validate functionality under real assay conditions—not just in isolation.

Endotoxin-Controlled Manufacturing

Endotoxin contamination is one of the most common failure points in diagnostic reagent manufacturing. Low-level endotoxin may not affect research use, but it can derail clinical and IVD programs.

Dharma Biologics operates endotoxin-aware manufacturing systems, including:

  • Controlled raw material sourcing
  • Endotoxin-minimizing fermentation strategies
  • Purification architectures designed for endotoxin removal
  • Routine endotoxin monitoring and trending

Endotoxin control is embedded in process design, not handled as cleanup.

Quality Systems Aligned to Diagnostic Reality

Diagnostics sit at the intersection of pharmaceutical and device expectations. Quality systems must be rigorous without becoming obstructive.

Dharma Biologics supports diagnostic manufacturing under ISO 13485–aligned frameworks, with documentation and controls appropriate for:

  • RUO products
  • IVD components
  • Early clinical diagnostics
  • Transition to regulated diagnostic kits

Our quality approach emphasizes:

  • Clear specifications
  • Meaningful in-process controls
  • Traceability across lots and components
  • Inspection readiness without bureaucracy

Quality exists to protect performance, not slow delivery.

Analytical & QC Support for Diagnostics

Diagnostics require analytics that reflect functional performance, not just molecular identity.

Dharma Biologics provides:

  • Activity-based enzyme assays
  • Binding and affinity characterization
  • Purity and impurity profiling
  • Stability studies under use-relevant conditions
  • Lot-release testing aligned with customer specifications

We design QC methods that scale with production, avoiding bottlenecks during ramp-up.

Scale-Up Without Drift

Diagnostic demand can change overnight. A platform that works at 10 liters must work at 1,000 liters without requalification chaos.

Dharma Biologics designs diagnostic processes for elastic scale-up, including:

  • Fermentation systems with predictable kinetics
  • Downstream processes tolerant of throughput variation
  • Inventory strategies aligned with demand volatility

This allows diagnostic companies to respond to market needs without sacrificing quality.

Supply Continuity & Network Execution

Diagnostics depend on uninterrupted supply. Single-site risk is unacceptable for critical reagents.

Through the Dharma CDMO Network, we enable:

  • Redundant manufacturing pathways
  • Cross-site tech transfer
  • Shared quality standards
  • Coordinated capacity expansion

Supply continuity is engineered, not hoped for.

Transitioning from RUO to Regulated Products

Many diagnostic innovations begin as research-use-only products and later move toward regulated applications. This transition often exposes foundational weaknesses.

Dharma Biologics supports this evolution deliberately by:

  • Designing RUO processes with future regulation in mind
  • Aligning documentation early
  • Implementing scalable QC frameworks
  • Supporting regulatory dossier preparation

This avoids painful rebuilds later.

Why Dharma Biologics for Diagnostics

Diagnostics demand humility. The biology may be elegant, but the execution must be relentless.

Dharma Biologics offers:

  • One of the most comprehensive diagnostic manufacturing platforms in India
  • Deep microbial and protein manufacturing expertise
  • ISO-aligned quality systems
  • Scale-ready infrastructure
  • Network-backed supply resilience

We do not chase novelty.
We deliver reliability.

From Bengaluru, Where Precision Is Non-Negotiable

Email our team at dharmabiologics.com

ಸರಿಯಾದ ಪ್ರಮಾಣ. ಸರಿಯಾದ ಫಲಿತಾಂಶ.